STAAR Surgical Company
STAA
Rank in Stocks
#7800
STAAR Surgical Company, along with its subsidiaries, specializes in... STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
Share Price
$24.55
Last synced: 2026-11-09
Market Cap
$1.23B
Change (1 day)
-2.62%
Change (1 year)
-10.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade STAAR Surgical Company (STAA)
Category
Healthcare
Operating Margin for STAAR Surgical Company (STAA)
Operating Margin as of November 2026 TTM: 10.32%
According to STAAR Surgical Company's latest financial reports, its current operating margin (TTM) is 10.32%. At the end of 2024 the company had an operating margin of -4.02%.
Operating Margin history for STAAR Surgical Company from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 10.32% | -356.72% |
| 2024 | -4.02% | -146.15% |
| 2023 | 8.71% | -43.44% |
| 2022 | 15.40% | 6.43% |
| 2021 | 14.47% | 249.52% |
| 2020 | 4.14% | -47.53% |
| 2019 | 7.89% | 48.31% |
| 2018 | 5.32% | -232.67% |
| 2017 | -4.01% | -73.88% |
| 2016 | -15.35% | 121.82% |
| 2015 | -6.92% | -35.33% |
| 2014 | -10.70% | -1,203.09% |
| 2013 | 0.97% | -150.79% |
| 2012 | -1.91% | -143.12% |
| 2011 | 4.43% | -193.66% |
| 2010 | -4.73% | -4.44% |
| 2009 | -4.95% | -81.81% |
| 2008 | -27.22% | 14.47% |
| 2007 | -23.78% | -1.61% |
| 2006 | -24.17% | 14.71% |
| 2005 | -21.07% | 7.23% |
| 2004 | -19.65% | 51.97% |
| 2003 | -12.93% | -12.28% |
| 2002 | -14.74% | -58.36% |
| 2001 | -35.40% | -5.30% |
| 2000 | -37.38% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -97.25% |
US
|
|
| 12.36% | -98.80% |
FR
|
|
| 9.83% | -99.05% |
US
|
|
| 31.11% | -96.99% |
JP
|
|
| 9.87% | -99.04% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about STAAR Surgical Company's operating margin
What is STAAR Surgical Company's operating margin?
STAAR Surgical Company's operating margin is 10.32%, as of Nov 2026.
What was STAAR Surgical Company's operating margin in 2024?
In 2024, STAAR Surgical Company's operating margin was -4.02%, compared with 8.71% in 2023.
How has STAAR Surgical Company's operating margin changed since 2019?
From 2019 to 2024, STAAR Surgical Company's operating margin was highest in 2022 (15.40%) and lowest in 2024 (-4.02%).
How does STAAR Surgical Company's operating margin compare with similar companies?
STAAR Surgical Company's operating margin (10.32%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.